Citation: | WANG Yanhu, XIAO Wei, FANG Shencun, WANG Huichi, HONG Mei, CHAI Lin, CHANG Yuan, ZHENG Wei, ZHU Nuo. Establishment and validation of a Nomogram model for predicting acute radiation dermatitis caused by intensity modulated radiotherapy for esophageal cancer[J]. Journal of Clinical Medicine in Practice, 2023, 27(1): 26-30, 59. DOI: 10.7619/jcmp.20222370 |
To establish a Nomogram model for predicting acute radiation dermatitis (ARD) caused by intensity modulated radiotherapy for esophageal cancer and verify its predictive ability.
A total of 179 thoracic esophageal cancer patients with intensity modulated radiation therapy were selected as the research objects, and they were divided into ≥ grade 3 ARD group and control group according to the incidence of ARD grade 3 or above. The predictors of ≥ grade 3 ARD caused by intensity modulated radiation therapy for esophageal cancer were screened by univariate, LASSO regression and multivariate Logistic regression analyses, and the Nomogram model was established.
Diabetes, albumin level < 30 g/L, Karnofsky score < 80, radiation dose ≥ 65 Gy and concurrent chemotherapy were the independent risk factors of ≥ grade 3 ARD caused by intensity modulated radiation therapy for esophageal cancer (P < 0.05). The model verification results showed that the consistency index (C-index) was 0.771, and the calibration curve was close to the ideal curve; the area under the curve (AUC) of receiver operating characteristic (ROC) curve was 0.778 (95%CI, 0.738 to 0.818), and the net benefit of the model was in the prediction range of 12% to 64%, indicating that the Nomogram model had good prediction ability.
The risk factors of ≥ grade 3 ARD caused by intensity modulated radiation therapy for esophageal cancer include diabetes, albumin level < 30 g/L, Karnofsky score < 80, radiotherapy dose ≥ 65 Gy and concurrent chemotherapy, and the Nomogram model based on risk factors has good predictive ability.
[1] |
中国医师协会放射肿瘤治疗医师分会, 中华医学会放射肿瘤治疗学分会, 中国抗癌协会肿瘤放射治疗专业委员会. 中国食管癌放射治疗指南(2019年版)[J]. 国际肿瘤学杂志, 2019, 46(7): 385-398. doi: 10.3760/cma.j.issn.1673-422X.2019.07.001
|
[2] |
DING S L, LI Y B, LIU H D, et al. Comparison of intensity modulated radiotherapy treatment plans between 1.5T MR-linac and conventional linac[J]. Technol Cancer Res Treat, 2021, 20: 1533033820985871.
|
[3] |
RYAN WOLF J, GEWANDTER J S, BAUTISTA J, et al. Utility of topical agents for radiation dermatitis and pain: a randomized clinical trial[J]. Support Care Cancer, 2020, 28(7): 3303-3311. doi: 10.1007/s00520-019-05166-5
|
[4] |
BOLTON L. Acute radiation therapy-related dermatitis[J]. Wounds, 2020, 32(2): 66-68.
|
[5] |
FINKELSTEIN S, KANEE L, BEHROOZIAN T, et al. Comparison of clinical practice guidelines on radiation dermatitis: a narrative review[J]. Support Care Cancer, 2022, 30(6): 4663-4674. doi: 10.1007/s00520-022-06829-6
|
[6] |
单青婷, 杜华平, 卢曼, 等. 缺血性脑卒中患者重组组织型纤溶酶原激活剂静脉溶栓24 h内症状反复波动的列线图预测模型[J]. 实用临床医药杂志, 2022, 26(12): 23-28. doi: 10.7619/jcmp.20220023
|
[7] |
REIFF J E. Radiation Therapy Oncology Group (RTOG)[J]. Jnci Monographs, 2013, 6(7/8): 81-82.
|
[8] |
YANG X J, REN H R, GUO X M, et al. Radiation-induced skin injury: pathogenesis, treatment, and management[J]. Aging (Albany NY), 2020, 12(22): 23379-23393.
|
[9] |
DAKUP P P, PORTER K I, GADDAMEEDHI S. The circadian clock protects against acute radiation-induced dermatitis[J]. Toxicol Appl Pharmacol, 2020, 399: 115040. doi: 10.1016/j.taap.2020.115040
|
[10] |
MVLLER K, MEINEKE V. Radiation-induced mast cell mediators differentially modulate chemokine release from dermal fibroblasts[J]. J Dermatol Sci, 2011, 61(3): 199-205. doi: 10.1016/j.jdermsci.2011.01.003
|
[11] |
彭丽娟, 周秀琴, 熊曼. 肿瘤放射治疗并发放射性皮炎的相关因素及护理[J]. 实用临床医药杂志, 2017, 21(16): 27-30. doi: 10.7619/jcmp.201716009
|
[12] |
欧丹, 王孝深, 胡超苏. 放射性皮炎预防与治疗研究进展[J]. 中华放射肿瘤学杂志, 2019, 28(2): 151-154. doi: 10.3760/cma.j.issn.1004-4221.2019.02.014
|
[13] |
ZENG R F, LIU C, LI L B, et al. Clinical efficacy of HiPorfin photodynamic therapy for advanced obstructive esophageal cancer[J]. Technol Cancer Res Treat, 2020, 19: 1533033820930335.
|
[14] |
YAO Z X, CHENG B. Predictive factors associated with radiation dermatitis in breast cancer[J]. Adv Skin Wound Care, 2021, 34(12): 1-8.
|
[15] |
BEHROOZIAN T, MILTON L, LI N, et al. Predictive factors associated with radiation dermatitis in breast cancer[J]. Cancer Treat Res Commun, 2021, 28: 100403. doi: 10.1016/j.ctarc.2021.100403
|
[16] |
BRAY F N, SIMMONS B J, WOLFSON A H, et al. Acute and chronic cutaneous reactions to ionizing radiation therapy[J]. Dermatol Ther (Heidelb), 2016, 6(2): 185-206. doi: 10.1007/s13555-016-0120-y
|
[17] |
CHEN Y, YE J J, ZHU Z F, et al. Comparing paclitaxel plus fluorouracil versus cisplatin plus fluorouracil in chemoradiotherapy for locally advanced esophageal squamous cell cancer: a randomized, multicenter, phase Ⅲ clinical trial[J]. J Clin Oncol, 2019, 37(20): 1695-1703. doi: 10.1200/JCO.18.02122
|
[18] |
HUANG J, HE T Y, YANG R H, et al. Clinical, dosimetric, and position factors for radiation-induced acute esophagitis in intensity-modulated (chemo) radiotherapy for locally advanced non-small-cell lung cancer[J]. Onco Targets Ther, 2018, 11(1): 6167-6175.
|
[19] |
KIŠONAS J, VENIUS J, GRYBAUSKAS M, et al. Acute radiation dermatitis evaluation with reflectance confocal microscopy: a prospective study[J]. Diagnostics (Basel), 2021, 11(9): 1670. doi: 10.3390/diagnostics11091670
|
[20] |
WANG Z M, CHEN M, SUN J, et al. Lyman-Kutcher-Burman normal tissue complication probability modeling for radiation-induced esophagitis in non-small cell lung cancer patients receiving proton radiotherapy[J]. Radiother Oncol, 2020, 146: 200-204.
|
[21] |
刘慧佳, 唐媛媛. 早期乳腺癌术后放疗患者放射性皮炎发生风险预测模型的构建及验证[J]. 现代医学, 2021, 49(6): 605-609. https://www.cnki.com.cn/Article/CJFDTOTAL-TDYX202106001.htm
|
[22] |
YOKOTA T, ZENDA S, OTA I, et al. Phase 3 randomized trial of topical steroid versus placebo for prevention of radiation dermatitis in patients with head and neck cancer receiving chemoradiation[J]. Int J Radiat Oncol Biol Phys, 2021, 111(3): 794-803.
|
1. |
肖礼红,鲁力,石伟. 中性粒细胞明胶酶相关脂质运载蛋白、肾损伤分子-1联合尿微量白蛋白检测对胰腺炎并发急性肾损伤的诊断价值. 中国当代医药. 2024(11): 117-120 .
![]() | |
2. |
李玲,管亚飞,张存,陈筱青,崔曙东,吴晶晶. 窒息相关新生儿急性肾损伤危险因素及临床特征分析. 实用临床医药杂志. 2024(18): 81-85 .
![]() | |
3. |
荣曾霞,熊绘,杨勋能. 低晶胶比液体复苏完成时限对成人重症急性胰腺炎休克患者病情及转归的影响. 实用临床医药杂志. 2024(23): 81-86 .
![]() | |
4. |
罗玮玮,董小武,王凝之,李瑶瑶,肖炜明,丁岩冰,孙云云. 基于Web of Science数据库对急性胰腺炎相关研究的文献计量与可视化分析. 实用临床医药杂志. 2023(19): 101-106 .
![]() |